Isabelle Gauthier

Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study

Glenwood Goss, Andrew Arnold, Frances A. Shepherd et al. · Journal of Clinical Oncology · 2009 · 244 citations

Medicine, Oncology, Pharmacology +16

Phase I and Pharmacokinetic Study of Daily Oral AZD2171, an Inhibitor of Vascular Endothelial Growth Factor Tyrosine Kinases, in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non–Small-Cell Lung Cancer: The National Cancer Institute of Canada Clinical Trials Group

Scott A. Laurie, Isabelle Gauthier, Andrew Arnold et al. · Journal of Clinical Oncology · 2008 · 120 citations

Medicine, Pharmacokinetics, Pharmacology +17

A phase I and pharmacokinetic study of daily oral cediranib, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer: A study of the National Cancer Institute of Canada Clinical Trials Group

Glenwood Goss, Frances A. Shepherd, Scott A. Laurie et al. · European Journal of Cancer · 2008 · 70 citations

Medicine, Oncology, Pharmacology +16

Patient perceptions of multiple sclerosis and its treatment

Isabelle Gauthier, de Sèze, Brudon · Patient Preference and Adherence · 2012 · 63 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +11

A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer

Daniel J. Renouf, Malcolm J. Moore, David W. Hedley et al. · Investigational New Drugs · 2010 · 53 citations

Medicine, Oncology, Pharmacology +12